GH Latest Headlines

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and Guardant Health (GH)

at www.tipranks.com (Fri, 10-Jul 8:30 AM)

Analyst Maintains Guardant Buy Rating, Citing Shield V2’s Competitive Edge and Strong Commercial Momentum in Colorectal Cancer Screening

at www.tipranks.com (Fri, 10-Jul 4:55 AM)

Bank of America Securities Keeps Their Buy Rating on Guardant Health (GH)

at www.tipranks.com (Mon, 6-Jul 6:16 AM)

American Cancer Society Endorses Guardant Health’s Shield Blood Test—A New Option for 50 Million Unscreened Adults

Market Chameleon (Wed, 27-May 8:15 AM)

FDA Approval Positions Guardant360 Liquid CDx as Largest and Most Comprehensive Liquid Biopsy Panel

Market Chameleon (Wed, 20-May 8:41 AM)

Guardant Health Grants 143,898 RSUs to 267 New Employees Under Inducement Plan

Market Chameleon (Tue, 19-May 11:47 AM)